Description
Tadarise-60 is a medication for the treatment of erectile dysfunction in men. Its active ingredient, Tadalafil, works by relaxing the muscles in the blood vessels of the penis, thereby increasing blood flow to the area and producing an erection.
One of the key characteristics of Tadarise-60 is its long-lasting effects. With an active half-life of 18-36 hours, this medication can provide relief from erectile dysfunction for a significant amount of time.
Tadarise-60 is classified as a PDE5 inhibitor, which means it works by inhibiting the enzyme responsible for breaking down cGMP, a substance that relaxes the smooth muscles of the penis. This allows for increased blood flow and improved erections.
The recommended dosage for Tadarise-60 in men is between 30-60 mg per day. It should be taken at least 30 minutes before sexual activity and not more than once per day.
One of the benefits of Tadarise-60 is that it does not cause acne or water retention, which are commonly associated with other medications used to treat erectile dysfunction. However, users should be aware that there is a possibility of headaches, back pain, and indigestion when taking this medication.
It is also important to note that Tadarise-60 does not have any hepatotoxicity or aromatization effects. However, there is a possibility of heartburn and acid reflux.
Tadarise-60 comes in a package of 10 pills, each containing 60 mg of Tadalafil. It is manufactured by Sunrise Remedies, a global pharmaceutical company dedicated to providing affordable and quality healthcare products.
Overall, Tadarise-60 is a safe and effective medication for the treatment of erectile dysfunction in men. Its long-lasting effects, low side effect profile, and ease of use make it a popular choice for many individuals dealing with this condition.
Chemical name: (6R-trans)-6-(1,3-benzodioxol-5-yl)- 2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino [1′, 2′
Formula: C22H19N3O4
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid
Reviews
There are no reviews yet.